Hippo signaling in cancer cells has been suggested to activate p53 by phosphorylating MST1/2 and LATS1/2 and inhibiting YAP/TAZ, coordinately promoting cellular senescence and the secretion of SASP factors. This evidence concerns the gene TP53 and cancer.